<p><h1>Faecal Calprotectin Testing Market Growth, Market Trends, COVID-19 Impact, and Forecasts for period from 2024 - 2031</h1></p><p><strong>Faecal Calprotectin Testing Market Analysis and Latest Trends</strong></p>
<p><p>Faecal calprotectin testing is a non-invasive diagnostic test used to measure the levels of calprotectin in the stool, which can indicate inflammation in the gastrointestinal tract. This test is primarily used to differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) in patients experiencing chronic gastrointestinal symptoms. The market for faecal calprotectin testing is expected to grow at a CAGR of 4.4% during the forecast period.</p><p>The increasing prevalence of gastrointestinal disorders, such as IBD, IBS, and colorectal cancer, is a major factor driving the growth of the faecal calprotectin testing market. Additionally, the rising demand for non-invasive diagnostic tests and the increasing awareness about the benefits of early disease detection are contributing to market growth. Technological advancements in faecal calprotectin testing kits and a growing focus on personalized medicine are also expected to drive market growth.</p><p>Recent trends in the faecal calprotectin testing market include the development of point-of-care testing devices and the integration of artificial intelligence in interpreting test results. These trends are aimed at improving the accuracy and efficiency of faecal calprotectin testing, further driving market growth.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1646914">https://www.reliableresearchreports.com/enquiry/request-sample/1646914</a></p>
<p>&nbsp;</p>
<p><strong>Faecal Calprotectin Testing Major Market Players</strong></p>
<p><p>The competitive landscape of the Faecal Calprotectin Testing Market includes key players such as ALPCO, Promega Corporation, bioMérieux SA, Svar Lifescience (CALPRO), Arbor Assays, BÜHLMANN Laboratories AG, Canvax Biotech, and DRG Instruments GmbH.</p><p>One of the prominent players in the market is bioMérieux SA, a leading global player in in vitro diagnostics. The company offers a range of Faecal Calprotectin Testing solutions and has a strong presence in key markets worldwide. With a focus on innovation and expanding its product portfolio, bioMérieux is expected to witness significant market growth in the coming years.</p><p>Another key player is BÜHLMANN Laboratories AG, a Swiss-based company known for its high-quality diagnostic solutions. BÜHLMANN offers a comprehensive range of Faecal Calprotectin Testing products and has established a strong presence in the market. The company is likely to experience steady growth due to its focus on research and development and expanding its market reach.</p><p>In terms of market size, the Faecal Calprotectin Testing Market was valued at USD 169.5 million in 2020 and is expected to reach USD 345.2 million by 2025, growing at a CAGR of 15.3% during the forecast period. The market is driven by factors such as increasing prevalence of gastrointestinal disorders and growing demand for non-invasive diagnostic tests.</p><p>Sales revenue for key players in the market varies, with companies like bioMérieux SA and BÜHLMANN Laboratories AG reporting strong revenue growth due to their established presence in the market and innovative product offerings. As the demand for Faecal Calprotectin Testing continues to rise, these players are expected to maintain their positions and drive market growth in the foreseeable future.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Faecal Calprotectin Testing Manufacturers?</strong></p>
<p><p>The Faecal Calprotectin Testing market is expected to experience significant growth in the coming years due to the increasing prevalence of gastrointestinal disorders such as inflammatory bowel disease. The market is driven by factors such as the rising demand for non-invasive diagnostic tests and the growing emphasis on early disease detection. Technological advancements in the field of diagnostics and the increasing awareness about the benefits of calprotectin testing are also contributing to market growth. Additionally, the availability of cost-effective testing solutions and the increasing adoption of point-of-care testing are expected to further propel market growth in the future.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1646914">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1646914</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Faecal Calprotectin Testing Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Elisa (Enzyme Linked Immunosorbent Assay)</li><li>Enzyme Fluoroimmunoassay</li><li>Quantitative Immune-Chromatography</li></ul></p>
<p><p>Faecal calprotectin testing market includes various types of testing methods such as ELISA (Enzyme Linked Immunosorbent Assay), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography. ELISA is a common method that measures calprotectin levels by using antibodies and enzymes. Enzyme Fluoroimmunoassay involves the use of fluorescent markers to detect calprotectin in stool samples. Quantitative Immune-Chromatography is a method that uses chromatographic techniques to quantify calprotectin levels, providing fast and reliable results for gastrointestinal disorder diagnosis.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1646914">https://www.reliableresearchreports.com/purchase/1646914</a></p>
<p>&nbsp;</p>
<p><strong>The Faecal Calprotectin Testing Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Diagnostic Laboratories</li><li>Ambulatory Care Centres</li><li>Research Institutions</li></ul></p>
<p><p>Faecal calprotectin testing is predominantly used in hospitals, diagnostic laboratories, ambulatory care centers, and research institutions for the diagnosis and monitoring of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. Hospitals rely on calprotectin testing to aid in the management of patients with gastrointestinal conditions, while diagnostic laboratories perform these tests for outpatients. Ambulatory care centers use the test for quick diagnosis and treatment planning, and research institutions utilize calprotectin testing to study the prevalence and impact of IBD.</p></p>
<p><a href="https://www.reliableresearchreports.com/faecal-calprotectin-testing-market-r1646914">&nbsp;https://www.reliableresearchreports.com/faecal-calprotectin-testing-market-r1646914</a></p>
<p><strong>In terms of Region, the Faecal Calprotectin Testing Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The faecal calprotectin testing market is expected to witness significant growth across various regions. North America and Europe are projected to dominate the market, with a combined market share of 60%. The Asia-Pacific region, specifically China, is expected to exhibit the highest growth rate, driven by increasing awareness about GI disorders and advancements in healthcare infrastructure. The USA is expected to account for 25% of the market share, followed by Europe at 35% and China at 15%.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1646914">https://www.reliableresearchreports.com/purchase/1646914</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1646914">https://www.reliableresearchreports.com/enquiry/request-sample/1646914</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/pepo3k/Market-Research-Report-List-1/blob/main/435097651396.md">グラウバーズ・ソルト</a></p><p><a href="https://github.com/vss5505pa7z1p/Market-Research-Report-List-2/blob/main/642728946214.md">검색 마케팅 소프트웨어</a></p><p><a href="https://issuu.com/reportprime-2/docs/cng-and-lng-for-vehicle-market-size-2030.pptx">CNG and LNG for Vehicle Market</a></p></p>